Evren Technologies

Evren Technologies is a private bioelectronic medical device company developing noninvasive neuromodulation products for post-traumatic stress disorder and related stress conditions. Its lead product is the Phoenix, a wearable earbud-style transcutaneous auricular vagus nerve stimulation device designed to reduce PTSD symptoms without drugs or implant surgery. The company also markets the Phoenix CR research system for clinical-trial and investigator use, and is using that system as the basis for its FDA pathway. Evren has received FDA Breakthrough Device Designation for its PTSD device and was accepted into the FDA TAP pilot program, indicating active regulatory engagement. The company appears to be advancing toward De Novo marketing authorization rather than running a traditional drug-style clinical pipeline.